Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients.


Journal

Cardiology journal
ISSN: 1898-018X
Titre abrégé: Cardiol J
Pays: Poland
ID NLM: 101392712

Informations de publication

Date de publication:
2023
Historique:
received: 19 07 2021
accepted: 06 08 2021
pubmed: 29 10 2021
medline: 4 3 2023
entrez: 28 10 2021
Statut: ppublish

Résumé

Several mechanisms have been suggested to explain positive cardiovascular effects observed in studies with sodium-glucose co-transporter 2 (SGLT2) inhibitors. The reduction in glucose reabsorption in proximal tubuli induced by SGLT2 inhibitors increases urinary glucose and sodium excretion resulting in increased osmotic diuresis and consequently in decreased plasma volume, followed by reduced preload. In addition, the hemodynamic effects of SGLT2 inhibition were observed in both hyper and euglycemic patients. Due to the complex and multidirectional effects induced by SGLT2 inhibitors, this originally antidiabetic group of drugs has been successfully used to treat patients with heart failure as well as for subjects with chronic kidney disease. Moreover, their therapeutic potential seems to be even broader than the indications studied to date.

Identifiants

pubmed: 34708866
pii: VM/OJS/J/84836
doi: 10.5603/CJ.a2021.0133
pmc: PMC9987542
doi:

Substances chimiques

Sodium-Glucose Transporter 2 Inhibitors 0
Sodium-Glucose Transporter 2 0
Glucosides 0
Hypoglycemic Agents 0
Sodium 9NEZ333N27
Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-149

Références

Circulation. 2021 Mar 2;143(9):875-877
pubmed: 33378214
J Am Heart Assoc. 2016 Jan 22;5(1):
pubmed: 26802105
Diabetes Care. 2015 Sep;38(9):1730-5
pubmed: 26180105
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
J Am Heart Assoc. 2020 Aug 18;9(16):e016270
pubmed: 32791029
Lancet. 2020 Sep 19;396(10254):819-829
pubmed: 32877652
Diabetes Metab. 2018 Dec;44(6):457-464
pubmed: 30266577
J Clin Endocrinol Metab. 2016 Mar;101(3):1249-56
pubmed: 26765576
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2207-2216
pubmed: 30354257
Eur J Pharmacol. 2014 Nov 5;742:47-54
pubmed: 25199965
Diabetes Obes Metab. 2018 Mar;20(3):479-487
pubmed: 29024278
Am J Nephrol. 2017 Dec 13;46(6):462-472
pubmed: 29253846
J Am Coll Cardiol. 2020 Feb 4;75(4):422-434
pubmed: 32000955
Circulation. 2020 Jan 14;141(2):90-99
pubmed: 31736335
Curr Med Res Opin. 2016 Aug;32(8):1441-51
pubmed: 27112628
Br J Clin Pharmacol. 2019 Jun;85(6):1337-1347
pubmed: 30767253
Sci Rep. 2020 Jul 21;10(1):12028
pubmed: 32694522
Curr Med Res Opin. 2019 Feb;35(2):341-349
pubmed: 30091642
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4253-4263
pubmed: 31162549
J Clin Invest. 2014 Feb;124(2):499-508
pubmed: 24463454
N Engl J Med. 2007 Mar 15;356(11):1140-51
pubmed: 17360992
Diabetologia. 2016 Sep;59(9):1860-70
pubmed: 27316632
Circulation. 2017 Oct 24;136(17):1643-1658
pubmed: 29061576
N Engl J Med. 2020 Oct 8;383(15):1413-1424
pubmed: 32865377
J Clin Invest. 1933 Nov;12(6):1083-90
pubmed: 16694183
Cardiovasc Diabetol. 2018 Oct 8;17(1):132
pubmed: 30296931
J Clin Med. 2020 Dec 19;9(12):
pubmed: 33352811
Physiol Rev. 2015 Apr;95(2):405-511
pubmed: 25834230
J Clin Invest. 1975 Apr;55(4):845-55
pubmed: 1120786
Pharmacology. 2015;95(1-2):50-8
pubmed: 25592409
Circulation. 2020 Feb 25;141(8):704-707
pubmed: 31707794
Am J Kidney Dis. 2021 Feb;77(2):280-286
pubmed: 32711072
Circulation. 2018 Jul 31;138(5):458-468
pubmed: 29526832
Patient Prefer Adherence. 2018 Mar 05;12:333-340
pubmed: 29551891
Eur Heart J. 2021 Mar 31;42(13):1203-1212
pubmed: 33420498
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Diab Vasc Dis Res. 2015 Mar;12(2):78-89
pubmed: 25616707
Physiol Rev. 2011 Apr;91(2):733-94
pubmed: 21527736
Int J Mol Med. 2019 May;43(5):2033-2043
pubmed: 30864731
Cell Metab. 2017 Jul 5;26(1):27-38
pubmed: 28506519
Front Endocrinol (Lausanne). 2019 Jul 03;10:441
pubmed: 31333586
Diabetologia. 2017 Mar;60(3):568-573
pubmed: 27752710
Circ Heart Fail. 2020 Sep;13(9):e007197
pubmed: 32894987
Diabetes Care. 2018 Feb;41(2):356-363
pubmed: 29203583
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Eur J Endocrinol. 2018 Apr;178(4):R113-R125
pubmed: 29371333
Diabetes Obes Metab. 2019 Dec;21(12):2667-2673
pubmed: 31407856

Auteurs

Jacek Kubica (J)

Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Aldona Kubica (A)

Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Klaudyna Grzelakowska (K)

Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Wioleta Stolarek (W)

Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Zofia Grąbczewska (Z)

Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Piotr Michalski (P)

Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Piotr Niezgoda (P)

Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland. piotr.niezgoda1986@gmail.com.

Stanisław Bartuś (S)

2nd Department of Cardiology, Collegium Medicum, Jagiellonian University, Krakow, Poland.

Andrzej Budaj (A)

Center of Postgraduate Medical Education, Department of Cardiology, Grochowski Hospital, Warsaw, Poland.

Mariusz Dąbrowski (M)

College of Medical Sciences, University of Rzeszow, Poland.

Jarosław Drożdż (J)

2nd Department of Cardiology, Chair of Cardiology, Cardiac Surgery and Vascular Diseases, Medical University of Lodz, Poland.

Ryszard Gellert (R)

Department of Nephrology and Internal Medicine, Center of Postgraduate Medical Education, Warsaw, Poland.

Miłosz J Jaguszewski (MJ)

1st Department of Cardiology, Medical University of Gdansk, Poland.

Piotr Jankowski (P)

1st Department of Cardiology, Collegium Medicum, Jagiellonian University, Krakow, Poland.

Jacek Legutko (J)

Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital in Krakow, Poland.

Maciej Lesiak (M)

Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.

Przemysław Leszek (P)

Department of Heart Failure and Transplantology, National Institute of Cardiology, Warsaw, Poland.

Jolanta Małyszko (J)

Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Poland.

Przemysław Mitkowski (P)

Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.

Jadwiga Nessler (J)

Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.

Krzysztof Pawlaczyk (K)

Department of Nephrology, Transplantology and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.

Jolanta Siller-Matula (J)

Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Poland.
Department of Cardiology, Medical University of Vienna, Austria.

Tomasz Stompór (T)

Chair of Internal Medicine Department of Nephrology, Hypertension and Internal Medicine, Medical Faculty, University of Warmia and Mazury in Olsztyn, Poland.

Bogumił Wolnik (B)

Department of Hypertension and Diabetology, Faculty of Medicine, Medical University of Gdansk, Poland.

Eliano Pio Navarese (EP)

Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH